394 related articles for article (PubMed ID: 11868612)
1. Involvement of hypoxia-inducible factor 1 in human cancer.
Semenza GL
Intern Med; 2002 Feb; 41(2):79-83. PubMed ID: 11868612
[TBL] [Abstract][Full Text] [Related]
2. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
3. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation.
Stoeltzing O; McCarty MF; Wey JS; Fan F; Liu W; Belcheva A; Bucana CD; Semenza GL; Ellis LM
J Natl Cancer Inst; 2004 Jun; 96(12):946-56. PubMed ID: 15199114
[TBL] [Abstract][Full Text] [Related]
4. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor.
Kallio PJ; Pongratz I; Gradin K; McGuire J; Poellinger L
Proc Natl Acad Sci U S A; 1997 May; 94(11):5667-72. PubMed ID: 9159130
[TBL] [Abstract][Full Text] [Related]
5. HIF-1 and tumor progression: pathophysiology and therapeutics.
Semenza GL
Trends Mol Med; 2002; 8(4 Suppl):S62-7. PubMed ID: 11927290
[TBL] [Abstract][Full Text] [Related]
6. The role of ARNT2 in tumor angiogenesis and the neural response to hypoxia.
Maltepe E; Keith B; Arsham AM; Brorson JR; Simon MC
Biochem Biophys Res Commun; 2000 Jun; 273(1):231-8. PubMed ID: 10873592
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression.
Semenza GL
Crit Rev Biochem Mol Biol; 2000; 35(2):71-103. PubMed ID: 10821478
[TBL] [Abstract][Full Text] [Related]
8. Expression of hypoxia-inducible factor 1: mechanisms and consequences.
Semenza GL
Biochem Pharmacol; 2000 Jan; 59(1):47-53. PubMed ID: 10605934
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
[TBL] [Abstract][Full Text] [Related]
10. Upregulated hypoxia-inducible factor-1 DNA binding activity to the vascular endothelial growth factor-A promoter mediates increased vascular permeability in donor lung grafts.
Abraham D; Krenn K; Seebacher G; Paulus P; Klepetko W; Aharinejad S
Ann Thorac Surg; 2004 May; 77(5):1751-5. PubMed ID: 15111179
[TBL] [Abstract][Full Text] [Related]
11. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
12. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia.
Salceda S; Beck I; Caro J
Arch Biochem Biophys; 1996 Oct; 334(2):389-94. PubMed ID: 8900415
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia inducible factor pathways as targets for functional foods.
Losso JN; Bawadi HA
J Agric Food Chem; 2005 May; 53(10):3751-68. PubMed ID: 15884793
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced angiogenesis during carcinogenesis.
Choi KS; Bae MK; Jeong JW; Moon HE; Kim KW
J Biochem Mol Biol; 2003 Jan; 36(1):120-7. PubMed ID: 12542982
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
16. The mouse gene for hypoxia-inducible factor-1alpha--genomic organization, expression and characterization of an alternative first exon and 5' flanking sequence.
Wenger RH; Rolfs A; Kvietikova I; Spielmann P; Zimmermann DR; Gassmann M
Eur J Biochem; 1997 May; 246(1):155-65. PubMed ID: 9210478
[TBL] [Abstract][Full Text] [Related]
17. HIF-1: using two hands to flip the angiogenic switch.
Semenza GL
Cancer Metastasis Rev; 2000; 19(1-2):59-65. PubMed ID: 11191064
[TBL] [Abstract][Full Text] [Related]
18. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
[TBL] [Abstract][Full Text] [Related]
19. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
[TBL] [Abstract][Full Text] [Related]
20. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
Salnikow K; Costa M; Figg WD; Blagosklonny MV
Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
